The decision to register the therapy was supported by data from the Phase III TRAILBLAZER-ALZ 2 and TRAILBLAZER-ALZ 6 trials.

Ever since President Donald Trump launched his campaign of raising tariffs on trading partners, his administration has ...

The 500 Festival has announced the winners of the float awards for the 2025 AES 500 Festival Parade. The parade is one of the ...

Tirzepatide discontinuation was associated with reduced cardiometabolic benefits especially among patients with body weight ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Everything from a live-action Disney remake to the newest Mission Impossible movie will be hitting screens this summer.

Part of the deal also includes an additional $2 cash payment per share upon the first commercial sale of Vigil’s Alzheimer’s ...

Around 13 percent of American adults regularly take an antidepressant, according to 2020 data, the most common of which are ...

Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

Within the PGIM Quant Solutions Large-Cap Core Fund, growth factors underperformed across large- and mid-cap portfolios in Q1 ...

While he may not have spent a lot of time suiting up in super suits, Michael Douglas played an important role in the MCU as ...

The PGIM Jennison Growth Fund returned - $10.0%, matching the Russell 1000 Growth Index, which also returned -10.0% in Q1 ...